APLEX BIO
APLEX Bio is a Swedish start-up founded in 2020 developing and commercializing a next-generation hyperplexed molecular detection technology for analysis of massive numbers of biomarkers both in-vitro and in-situ. The technology enables applications from research to mass-scale in-vitro diagnostics (IVD) and precision diagnostics. APLEX Bio is based in Stockholm at the Karolinska Institute (KI) campus and is part of KI Innovations.
APLEX BIO
Industry:
Biotechnology Health Diagnostics Life Science
Founded:
2020-01-01
Address:
Solna, Stockholms Lan, Sweden
Country:
Sweden
Website Url:
http://www.aplex.bio
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
14.23 M SEK
Technology used in webpage:
Google Google Cloud Wix
Similar Organizations
Instadiagnostics
Instadiagnostics Inc., is developing a rapid, quantitative, point-of-care (POC) diagnostic platform.
Halo Labs
Halo Labs is a biotechnology company that specializes in analytical instrumentation and biopharma.
Prolocor
Prolocor is a biotechnology company that develops diagnostic tests for cardiovascular diseases.
Renovacor
Renovacor is a biopharmaceutical company that focuses on developing transformative gene therapy‑based treatments for cardiovascular disease.
Slingshot Biosciences
Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.
Current Advisors List
Current Employees Featured
Founder
Official Site Inspections
http://www.aplex.bio
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.171
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "Aplex Bio"
Aplex Bio - Crunchbase Company Profile & Funding
APLEX Bio is a Swedish start-up founded in 2020 developing and commercializing a next-generation hyperplexed molecular detection …See details»
Aplex Bio 2025 Company Profile: Valuation, Funding & Investors
Aplex Bio was founded in 2020. Where is Aplex Bio headquartered? Aplex Bio is headquartered in Solna, Sweden. What is the size of Aplex Bio? Aplex Bio has 12 total employees. What …See details»
Aplex Bio AB Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Aplex Bio AB of Solna, Stockholm. Get the latest business insights from Dun & Bradstreet.See details»
Aplex Bio - Jobylon
APLEX Bio, a Swedish start-up company founded in 2020, is developing and commercializing a next-generation Hyperplex PCR™ technology for analysis of massive numbers of biomarkers. The technology enables applications from …See details»
APLEX Bio - KI Innovations
APLEX Bio develops reagents that enable highly parallelized detection of biomarkers in a disruptively easy and cost-efficient way. The technology is set to allow significantly simpler and faster gene expression analysis directly in …See details»
Aplex Bio - Products, Competitors, Financials, Employees, …
Aplex Bio specializes in advanced molecular diagnostics, focusing on their proprietary Hyperplex PCR technology within the biotechnology sector. Use the CB Insights Platform to explore …See details»
Aplex Bio - nome.nu
Aplex Bio develops next-generation hyperplexed PCR solutions. The technology is able to detect more than 100 target molecules in a sample – simultaneously and with ultra-high sensitivity …See details»
Technology - APLEX Bio
The Nanopixels are novel fluorescent nanoprobes invented and developed by Aplex Bio. Compared to regular fluorophores, they are brighter, more photostable and have unique fluorescent properties making them capable of generating …See details»
Aplex Bio - VentureRadar
APLEX Bio is a company committed to advancing the field of molecular analysis. Their mission is to enable impactful, knowledge-based decisions in healthcare and sustainability without …See details»
APLEX Bio - eqtfoundation.com
Sep 24, 2024 APLEX Bio’s Hyperplex hpPCR technology is set to allow significantly simpler and faster genetic analysis directly than what is possible today. Current solutions are typically limited to around five simultaneous …See details»
Aplex Bio - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Dec 31, 2021: Seed Round - …See details»
Swedish Startup Aplex Bio Debuts 100-Target 'Hyperplex' PCR
Since 2021, when a group of visionaries came together, we have been on an incredible journey together at Aplex Bio. Watching our technology evolve from an idea into a game-changing …See details»
Aplex Bio AB | Institution outputs | Nature Index
The articles listed below published by authors from Aplex Bio AB, organized by journal and article, represent the research output in Count and Share according to the parameters selected above.See details»
News - APLEX Bio
Apr 4, 2025 APLEX Bio announces it has raised 14 MSEK (€1.3M) for developing its massive multiplexing technology that enables detection of more than 100 biomolecules (DNA, RNA, …See details»
New company that combines nano- and biochemistry launched
Mar 7, 2022 APLEX Bio’s technology is an example of how to achieve mass scale precision diagnostics on a routine-basis to better address current and future pandemics. Massive …See details»